Cargando…

Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial

BACKGROUND: Despite decades of experience with praziquantel treatment in school-aged children (SAC) and adults, we still face considerable knowledge gaps relevant to the successful treatment of preschool-aged children (PSAC). This study aimed to assess the efficacy and safety of escalating praziquan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coulibaly, Jean T., Panic, Gordana, Yapi, Richard B., Kovač, Jana, Barda, Beatrice, N’Gbesso, Yves K., Hattendorf, Jan, Keiser, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984412/ https://www.ncbi.nlm.nih.gov/pubmed/29855373 http://dx.doi.org/10.1186/s12916-018-1066-y

Ejemplares similares

Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium
por: Coulibaly, Jean T., et al.
Publicado: (2012)

Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial
por: Coulibaly, Jean T, et al.
Publicado: (2017)

Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial
por: Barda, Beatrice, et al.
Publicado: (2016)

Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial
por: Barda, Beatrice, et al.
Publicado: (2017)

Efficacy and safety of ascending dosages of albendazole against Trichuris trichiura in preschool-aged children, school-aged children and adults: A multi-cohort randomized controlled trial
por: Patel, Chandni, et al.
Publicado: (2020)

Evaluation of the Clinitek®, a point-of-care urinalysis system for the measurement of clinically significant urinary metabolites and detection of haematuria in Schistosoma haematobium infected children in southern Côte d’Ivoire
por: Panic, Gordana, et al.
Publicado: (2019)

Efficacy and Safety of Albendazole in Hookworm-infected Preschool-aged Children, School-aged Children, and Adults in Côte d’Ivoire: A Phase 2 Randomized, Controlled Dose-finding Trial
por: Patel, Chandni, et al.
Publicado: (2020)

In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
por: Kovač, Jana, et al.
Publicado: (2017)

Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children
por: Stete, Katarina, et al.
Publicado: (2012)

Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome
por: Schneeberger, Pierre H. H., et al.
Publicado: (2018)

Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
por: Keiser, Jennifer, et al.
Publicado: (2014)

Accuracy of Urine Circulating Cathodic Antigen Test for the Diagnosis of Schistosoma mansoni in Preschool-Aged Children before and after Treatment
por: Coulibaly, Jean T., et al.
Publicado: (2013)

Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
por: King, C H, et al.
Publicado: (2000)

Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
por: Coles, G C, et al.
Publicado: (2001)

Efficacy of Praziquantel against Schistosoma haematobium in Dulshatalo village, western Ethiopia
por: Mekonnen, Asaye, et al.
Publicado: (2013)

Efficacy of praziquantel in the treatment of Schistosoma haematobium infection among school-age children in rural communities of Abeokuta, Nigeria
por: Ojurongbe, Olusola, et al.
Publicado: (2014)

Population genetic structure of Schistosoma haematobium and Schistosoma haematobium × Schistosoma bovis hybrids among school-aged children in Côte d’Ivoire
por: Angora, Etienne K., et al.
Publicado: (2022)

Efficacy of Artesunate + Sulfamethoxypyrazine/Pyrimethamine versus Praziquantel in the Treatment of Schistosoma haematobium in Children
por: Sissoko, Mahamadou S., et al.
Publicado: (2009)

Efficacy and safety of praziquantel against Schistosoma haematobium in the Ikata-Likoko area of southwest Cameroon
por: Ebai, Calvin Bisong, et al.
Publicado: (2017)

Organomegaly in Mali before and after praziquantel treatment. A possible association with Schistosoma haematobium
por: Stecher, Chalotte Willemann, et al.
Publicado: (2017)

Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children
por: Osakunor, Derick N. M., et al.
Publicado: (2020)

Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel
por: Ahmed, Abedaziz M, et al.
Publicado: (2012)

A Praziquantel Treatment Study of Immune and Transcriptome Profiles in Schistosoma haematobium-Infected Gabonese Schoolchildren
por: Labuda, Lucja A, et al.
Publicado: (2019)

Schistosoma haematobium
por: Corsini Campioli, Cristina, et al.
Publicado: (2022)

Limited efficacy of repeated praziquantel treatment in Schistosoma mansoni infections as revealed by highly accurate diagnostics, PCR and UCP-LF CAA (RePST trial)
por: Hoekstra, Pytsje T., et al.
Publicado: (2022)

Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel
por: Mutapi, Francisca, et al.
Publicado: (2011)

Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies
por: RUJENI, N, et al.
Publicado: (2012)

Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya
por: Kimani, Bridget W., et al.
Publicado: (2018)

Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
por: Dejon-Agobé, Jean Claude, et al.
Publicado: (2019)

Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST)
por: Hoekstra, Pytsje T., et al.
Publicado: (2020)

A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire
por: Coulibaly, Jean T., et al.
Publicado: (2018)

Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community
por: Adewale, Babatunde, et al.
Publicado: (2018)

Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
por: Dejon-Agobé, Jean Claude, et al.
Publicado: (2021)

Development of an in vitro drug screening assay using Schistosoma haematobium schistosomula
por: Marxer, Monika, et al.
Publicado: (2012)

Effect of Schistosoma haematobium infection on the cognitive functions of preschool age children and benefits of treatment from an endemic area in Zimbabwe
por: Kasambala, Maritha, et al.
Publicado: (2022)

Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) – single versus multiple praziquantel treatments in school-aged children in Côte d’Ivoire: a study protocol for an open-label, randomised controlled trial
por: Hoekstra, P. T., et al.
Publicado: (2018)

Prevalence and seasonal transmission of Schistosoma haematobium infection among school-aged children in Kaedi town, southern Mauritania
por: Gbalégba, N’Guessan G C, et al.
Publicado: (2017)

Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel
por: Kemal, Makida, et al.
Publicado: (2019)

Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni
por: Panic, Gordana, et al.
Publicado: (2015)

Prevalence and factors associated with ongoing transmission of Schistosoma haematobium after 12 rounds of Praziquantel Mass Drug Administration among school age children in Southern Tanzania
por: Malibiche, Ditrick, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fmq6nle5sqpn3mv4d3vuh7kdqs